Amit Sachdev

CIK: 0001406338

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (34.6%)

Position reduction

Option Exercises (M)2 (7.7%)

Derivative conversions

Awards (A)7 (26.9%)

Compensation grants

Other (G, F, J, C, D, …)8 (30.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VRTX

VERTEX PHARMACEUTICALS INC / MA

Officer

Discretionary Trading P&L

Holdings

Transaction History (26 total)

VRTX
VERTEX PHARMACEUTICALS INC / MA
Jul 21, 2026
Award(A)
Direct
8.3K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 25, 2026
Sale(S)
Direct
1.8K shares at avg. $486.35$898K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 24, 2026
Tax Payment(F)
Direct
1.5K shares at avg. $485.11$736K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 19, 2026
Sale(S)
Direct
7.2K shares at avg. $469.61$3.4M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 19, 2026
Sale(S)
Direct
19.7K shares at avg. $468.57$9.2M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 19, 2026
Sale(S)
Direct
4.2K shares at avg. $471.43$2.0M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 19, 2026
Sale(S)
Direct
11.7K shares at avg. $470.54$5.5M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 19, 2026
Sale(S)
Direct
920 shares at avg. $463.91$427K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 19, 2026
Sale(S)
Direct
2.7K shares at avg. $465.05$1.3M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 19, 2026
Sale(S)
Direct
1.8K shares at avg. $465.80$861K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 19, 2026
Sale(S)
Direct
10.3K shares at avg. $467.75$4.8M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 19, 2026
Exercise(M)
Direct
23.5K shares at avg. $155.57$3.7M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 19, 2026
Exercise(M)
Direct
25K shares at avg. $187.53$4.7M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 17, 2026
Award(A)
Direct
5.8K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 17, 2026
Tax Payment(F)
Direct
2.1K shares at avg. $483.75$1.0M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 13, 2026
Tax Payment(F)
Direct
3.5K shares at avg. $487.76$1.7M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 10, 2026
Tax Payment(F)
Direct
2.1K shares at avg. $468.41$964K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jan 22, 2026
Award(A)
Direct
3.9K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Jan 22, 2026
Award(A)
Direct
7.9K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 26, 2025
Tax Payment(F)
Direct
3.7K shares at avg. $479.61$1.8M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 24, 2025
Tax Payment(F)
Direct
2.5K shares at avg. $483.28$1.2M
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 14, 2025
Tax Payment(F)
Direct
2.1K shares at avg. $463.46$991K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 12, 2025
Award(A)
Direct
6.2K shares-
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 10, 2025
Tax Payment(F)
Direct
2.1K shares at avg. $467.98$962K
VRTX
VERTEX PHARMACEUTICALS INC / MA
Feb 4, 2025
Award(A)
Direct
7.1K shares-

		Type	Shares	Price		Ownership
Jul 21, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	8,251	-	$0	Direct
Feb 25, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	1,846	$486.35	$897,802	Direct
Feb 24, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	1,518	$485.11	$736,397	Direct
Feb 19, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	7,241	$469.61	$3,400,446	Direct
Feb 19, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	19,662	$468.57	$9,213,023	Direct
Feb 19, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	4,237	$471.43	$1,997,449	Direct
Feb 19, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	11,712	$470.54	$5,510,964	Direct
Feb 19, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	920	$463.91	$426,797	Direct
Feb 19, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	2,730	$465.05	$1,269,587	Direct
Feb 19, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	1,848	$465.80	$860,798	Direct
Feb 19, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Sale(S)	10,263	$467.75	$4,800,518	Direct
Feb 19, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Exercise(M)	23,479	$155.57	$3,652,628	Direct
Feb 19, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Exercise(M)	25,026	$187.53	$4,693,126	Direct
Feb 17, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	5,789	-	$0	Direct
Feb 17, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	2,140	$483.75	$1,035,225	Direct
Feb 13, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	3,548	$487.76	$1,730,572	Direct
Feb 10, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	2,057	$468.41	$963,519	Direct
Jan 22, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	3,883	-	$0	Direct
Jan 22, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	7,866	-	$0	Direct
Feb 26, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	3,703	$479.61	$1,775,996	Direct
Feb 24, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	2,470	$483.28	$1,193,702	Direct
Feb 14, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	2,139	$463.46	$991,341	Direct
Feb 12, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	6,211	-	-	Direct
Feb 10, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Tax Payment(F)	2,056	$467.98	$962,167	Direct
Feb 4, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	Award(A)	7,114	-	-	Direct

1-25 of 26 transactions

About Sachdev Amit

Sachdev Amit (SEC CIK 0001406338) files insider reports with the SEC as EVP Chief Patient & Ext Af Off of VERTEX PHARMACEUTICALS INC / MA (VRTX).

Signal8 holds 13 ownership filings by Sachdev Amit, all Form 4s, filed between Feb 6, 2025 and Jul 23, 2026. Those filings report 26 transactions, from Feb 4, 2025 to Jul 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sachdev Amit's filings is in BOSTON, MA.

Recent filings by Sachdev Amit

Jul 21, 2026: Grant or award of VRTX shares (Form 4, code A).
Feb 25, 2026: Open-market sale of VRTX shares (Form 4, code S).
Feb 24, 2026: Tax withholding of VRTX shares (Form 4, code F).
Feb 19, 2026: Open-market sales of VRTX shares (8 lines, Form 4, code S).
Feb 19, 2026: Option exercises of VRTX shares (2 lines, Form 4, code M).

Other insiders filing for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Brennan Daniel J., Director
SACHS BRUCE I, Director
Garber Alan M, Director
van Grunsven Jasper, EVP, CP and NPPO
Ambrose Kristen, SVP & Chief Accounting Officer
Tatsis Ourania, EVP, Chief Reg. & Quality Off.

How to read Form 4 transaction codes